Real-World Experience with Ceftolozane-Tazobactam for Multidrug-Resistant Gram-Negative Bacterial Infections

Our objective was to describe the prescribing practices, clinical characteristics, and outcomes of patients treated with ceftolozane-tazobactam (C/T) for multidrug-resistant (MDR) Gram-negative infections. This was a multicenter, retrospective, cohort study at eight U.S. medical centers (2015 to 201...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Antimicrob Agents Chemother
Päätekijät: Jorgensen, Sarah C. J., Trinh, Trang D., Zasowski, Evan J., Lagnf, Abdalhamid M., Simon, Samuel P., Bhatia, Sahil, Melvin, Sarah M., Steed, Molly E., Finch, Natalie A., Morrisette, Taylor, Estrada, Sandy J., Rosenberg, Joshua R., Davis, Susan L., Rybak, Michael J.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: American Society for Microbiology 2020
Aiheet:
Clinical Therapeutics
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7179316/
https://ncbi.nlm.nih.gov/pubmed/31932379
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.02291-19
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia